newsfilter
← Latest News
GlobeNewswire·

Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional Investors Conference

BURLINGTON, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in...